2.4.0.8 Html 202 286 1 true 59 0 false 5 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.oncosec.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0010 - Statement - Consolidated Balance Sheets Sheet http://www.oncosec.com/role/BalanceSheet Consolidated Balance Sheets false false R3.htm 0015 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.oncosec.com/role/BalanceSheetParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 0020 - Statement - Consolidated Statements of Operations Sheet http://www.oncosec.com/role/StatementOfIncome Consolidated Statements of Operations false false R5.htm 0030 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.oncosec.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity (Deficit) false false R6.htm 0035 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Sheet http://www.oncosec.com/role/StatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) false false R7.htm 0040 - Statement - Consolidated Statements of Cash Flows Sheet http://www.oncosec.com/role/CashFlows Consolidated Statements of Cash Flows false false R8.htm 1010 - Disclosure - Nature of Operations and Basis of Presentation Sheet http://www.oncosec.com/role/DisclosureNatureOfOperationsAndBasisOfPresentation Nature of Operations and Basis of Presentation false false R9.htm 1020 - Disclosure - Significant Accounting Policies Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies false false R10.htm 1030 - Disclosure - Cash and Cash Equivalents and Liquidity Sheet http://www.oncosec.com/role/DisclosureCashAndCashEquivalentsAndLiquidity Cash and Cash Equivalents and Liquidity false false R11.htm 1040 - Disclosure - Fair Value of Financial Instruments Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments false false R12.htm 1050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreement Intangible Asset Acquisition and Cross License Agreement false false R13.htm 1060 - Disclosure - Acquisition Obligation Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligation Acquisition Obligation false false R14.htm 1070 - Disclosure - Private Placements and Public Offerings Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferings Private Placements and Public Offerings false false R15.htm 1080 - Disclosure - Other Equity and Common Stock Transactions Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactions Other Equity and Common Stock Transactions false false R16.htm 1090 - Disclosure - Stock-Based Compensation Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R17.htm 1100 - Disclosure - Income Taxes Sheet http://www.oncosec.com/role/DisclosureIncomeTaxes Income Taxes false false R18.htm 1110 - Disclosure - Commitments and Contingencies Sheet http://www.oncosec.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R19.htm 1120 - Disclosure - Related Party Transactions Sheet http://www.oncosec.com/role/DisclosureRelatedPartyTransactions Related Party Transactions false false R20.htm 1130 - Disclosure - Subsequent Events Sheet http://www.oncosec.com/role/DisclosureSubsequentEvents Subsequent Events false false R21.htm 2020 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) false false R22.htm 3020 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesTables Significant Accounting Policies (Tables) false false R23.htm 3050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement (Tables) Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreementTables Intangible Asset Acquisition and Cross License Agreement (Tables) false false R24.htm 3070 - Disclosure - Private Placements and Public Offerings (Tables) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingsTables Private Placements and Public Offerings (Tables) false false R25.htm 3090 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) false false R26.htm 3100 - Disclosure - Income Taxes (Tables) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R27.htm 3110 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.oncosec.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R28.htm 4010 - Disclosure - Nature of Operations and Basis of Presentation (Details) Sheet http://www.oncosec.com/role/DisclosureNatureOfOperationsAndBasisOfPresentationDetails Nature of Operations and Basis of Presentation (Details) false false R29.htm 4020 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesDetails Significant Accounting Policies (Details) false false R30.htm 4021 - Disclosure - Significant Accounting Policies (Details 2) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesDetails2 Significant Accounting Policies (Details 2) false false R31.htm 4030 - Disclosure - Cash and Cash Equivalents and Liquidity (Details) Sheet http://www.oncosec.com/role/DisclosureCashAndCashEquivalentsAndLiquidityDetails Cash and Cash Equivalents and Liquidity (Details) false false R32.htm 4040 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) false false R33.htm 4050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement (Details) Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreementDetails Intangible Asset Acquisition and Cross License Agreement (Details) false false R34.htm 4060 - Disclosure - Acquisition Obligation (Details) Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligationDetails Acquisition Obligation (Details) false false R35.htm 4061 - Disclosure - Acquisition Obligation (Details 2) Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligationDetails2 Acquisition Obligation (Details 2) false false R36.htm 4070 - Disclosure - Private Placements and Public Offerings (Details) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingsDetails Private Placements and Public Offerings (Details) false false R37.htm 4071 - Disclosure - Private Placements and Public Offerings (Details 2) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingsDetails2 Private Placements and Public Offerings (Details 2) false false R38.htm 4080 - Disclosure - Other Equity and Common Stock Transactions (Details) Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactionsDetails Other Equity and Common Stock Transactions (Details) false false R39.htm 4081 - Disclosure - Other Equity and Common Stock Transactions (Details 2) Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactionsDetails2 Other Equity and Common Stock Transactions (Details 2) false false R40.htm 4090 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationDetails Stock-Based Compensation (Details) false false R41.htm 4091 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationDetails2 Stock-Based Compensation (Details 2) false false R42.htm 4100 - Disclosure - Income Taxes (Details) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R43.htm 4101 - Disclosure - Income Taxes (Details 2) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesDetails2 Income Taxes (Details 2) false false R44.htm 4102 - Disclosure - Income Taxes (Details 3) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesDetails3 Income Taxes (Details 3) false false R45.htm 4110 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.oncosec.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R46.htm 4130 - Disclosure - Subsequent Events (Details) Sheet http://www.oncosec.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports Element oncs_StockIssuanceCostsPlacementAgentFeesPercentage had a mix of decimals attribute values: 0 2. Element oncs_StockIssuanceCostsPlacementExpenseReimbursementPercentage had a mix of decimals attribute values: 0 2. Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 2 4. Process Flow-Through: 0010 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Jul. 31, 2011' Process Flow-Through: Removing column 'Jul. 31, 2010' Process Flow-Through: Removing column 'Jul. 31, 2009' Process Flow-Through: Removing column 'Jul. 31, 2008' Process Flow-Through: 0015 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Jun. 24, 2011' Process Flow-Through: Removing column 'Mar. 02, 2011' Process Flow-Through: Removing column 'Feb. 28, 2011' Process Flow-Through: 0020 - Statement - Consolidated Statements of Operations Process Flow-Through: Removing column '6 Months Ended Jul. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2009' Process Flow-Through: 0035 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Process Flow-Through: 0040 - Statement - Consolidated Statements of Cash Flows oncs-20131025.xml oncs-20131025.xsd oncs-20131025_cal.xml oncs-20131025_def.xml oncs-20131025_lab.xml oncs-20131025_pre.xml true true